{"id":18,"date":"2019-01-16T16:13:02","date_gmt":"2019-01-16T07:13:02","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol-test\/?page_id=18"},"modified":"2025-07-01T11:16:10","modified_gmt":"2025-07-01T02:16:10","slug":"publications","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/publications\/","title":{"rendered":"\u7dcf\u8aac\u30fb\u8457\u66f8"},"content":{"rendered":"

2025<\/h4>\n
    \n
  1. \u6a0b\u7530\u4eac\u5b50<\/span><\/span>\uff1a\u8840\u7ba1\u306e\u708e\u75c7\u6027\u5909\u5316\u3068\u75c5\u614b\u9032\u884c, \u75c5\u7406\u3068\u81e8\u5e8a, \u6587\u5149\u5802 43(7), 733-735, 2025<\/span><\/li>\n<\/ol>\n

    2024<\/h4>\n
      \n
    1. \u6a0b\u7530\u4eac\u5b50<\/u>: \u6b6f\u5b66\u751f\u306e\u305f\u3081\u306e\u57fa\u790e\u75c5\u7406\u5b66, Chapter8 \u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u304a\u3088\u3073\u767a\u751f\u306e\u7570\u5e38, \u201c\u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u306e\u57fa\u672c\u201d, \u533b\u6b6f\u85ac\u51fa\u7248, 170-175, 2024\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n<\/ol>\n

      2023<\/h4>\n
        \n
      1. \u6a0b\u7530\u4eac\u5b50<\/span><\/span>: \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u7de8\u96c6\uff0c\u65b0\u81e8\u5e8a\u816b\u760d\u5b66\uff08\u6539\u8a02\u7b2c7\u7248\uff09\uff0d\u304c\u3093\u306e\u767a\u751f\u3068\u9032\u5c55\u6a5f\u69cb\uff0d, \u201c\u8840\u7ba1\u65b0\u751f\u201d, \u5357\u6c5f\u5802, 49-52, 2024\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/span><\/li>\n
      2. \u6a0b\u7530\u4eac\u5b50<\/u>,<\/span> \u9593\u77f3\u5948\u6e56, \u677e\u7530\u3000\u5f69, \u6a0b\u7530\u6cf0\u6d69: \u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u591a\u69d8\u6027\u3068\u816b\u760d\u514d\u75ab, \u8a3a\u65ad\u75c5\u7406, \u65e5\u672c\u75c5\u7406\u5b66\u4f1a, 40(2), 133-138, 2023<\/span><\/li>\n<\/ol>\n

        2021<\/h4>\n
          \n
        1. \u6a0b\u7530\u4eac\u5b50<\/u>, \u9593\u77f3\u5948\u6e56: \u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u591a\u69d8\u6027\u3068\u304c\u3093\u60aa\u6027\u5316\u4fc3\u9032\u6a5f\u69cb, \u85e4\u7530\u76f4\u4e5f\u7de8\uff0c\u5b9f\u9a13\u533b\u5b66\u3000\u5897\u520a\u300c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b1\u7d30\u80de\u30ec\u30d9\u30eb\u3067\u6311\u3080\u300d\uff0c39(12)\uff0c79-82, 2021<\/li>\n
        2. \u6a0b\u7530\u4eac\u5b50<\/u>: \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u7de8\u96c6\uff0c\u65b0\u81e8\u5e8a\u816b\u760d\u5b66\uff08\u6539\u8a02\u7b2c6\u7248\uff09\uff0d\u304c\u3093\u85ac\u7269\u7642\u6cd5\u5c02\u9580\u533b\u306e\u305f\u3081\u306b\uff0d, \u201c\u8840\u7ba1\u65b0\u751f\u201d, \u5357\u6c5f\u5802, 42-46, 2021\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n<\/ol>\n

          2020<\/h4>\n
            \n
          1. \u9593\u77f3\u5948\u6e56, \u6a0b\u7530\u4eac\u5b50<\/u>: \u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u304a\u3051\u308b\u7570\u5e38\u6027\u89e3\u660e\u3068\u305d\u306e\u5236\u5fa1\uff0c\u9ad8\u5009\u4f38\u5e78\u7de8\u300c\u7d30\u80de\u300d\uff0d\u7279\u96c6\u3000\u304c\u3093\u306e\u9032\u5c55\u306b\u304a\u3051\u308b\u8840\u7ba1\u65b0\u751f\u3068\u514d\u75ab\uff0d\uff0c\u30cb\u30e5\u30fc\u30b5\u30a4\u30a8\u30f3\u30b9\u793e\uff0c53(2)\uff0c49-52\uff0c2021<\/li>\n
          2. \u6a0b\u7530\u4eac\u5b50<\/u>, \u9593\u77f3\u5948\u6e56: \u8840\u7ba1\u5185\u76ae\u5897\u6b96\u56e0\u5b50, \u300c\u7523\u79d1\u3068\u5a66\u4eba\u79d1 \u7279\u96c6 \u5206\u5b50\u6a19\u7684\u85ac\u3092\u6975\u3081\u308b\u2015\u57fa\u790e\u304b\u3089\u81e8\u5e8a\u307e\u3067\u2015\u300d, \u8a3a\u65ad\u3068\u6cbb\u7642\u793e, 87(10), 1145-1149, 2020<\/li>\n
          3. \u9593\u77f3\u5948\u6e56, Annan DA, \u6a0b\u7530\u4eac\u5b50<\/u>: \u300c\u304c\u3093\u6cbb\u7642\u6a19\u7684\u3068\u3057\u3066\u306e\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\u300d, \u300e\u708e\u75c7\u3068\u514d\u75ab\u300f, \u5148\u7aef\u533b\u5b66\u793e, 28(5), 35-40, 2020<\/li>\n
          4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u81e8\u5e8a\u5fdc\u7528\u3078\u306e\u5c55\u671b\uff0c\u533b\u5b66\u306e\u3042\u3086\u307f\u201c\u8840\u7ba1\u65b0\u751f\uff0d\u57fa\u790e\u3068\u81e8\u5e8a\u201d\uff0c270(1)\uff0c107-110, 2020<\/li>\n<\/ol>\n

            2019<\/h4>\n
              \n
            1. Hida K<\/u>, Maishi N, Hida Y: (2019) Tumor Blood Vessels as Targets for Cancer Therapy. In: Matsumura Y., Tarin D. (eds) Cancer Drug Delivery Systems Based on the Tumor Microenvironment. Springer, 41-56, Tokyo, 2019<\/li>\n
            2. \u6a0b\u7530\u4eac\u5b50<\/u>,<\/u> \u9593\u77f3\u5948\u6e56\uff1a\u9ad8\u5009\u4f38\u5e78\u4f01\u753b, \u304c\u3093\u514d\u75ab\u306e\u52b9\u679c\u3092\u5de6\u53f3\u3059\u308b\u816b\u760d\u8840\u7ba1\u3068\u514d\u75ab\u74b0\u5883\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u3068\u816b\u760d\u514d\u75ab\u201d, \u5b9f\u9a13\u533b\u5b6637(19), \u7f8a\u571f\u793e, 3201-3205, 2019\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n
            3. <\/li>\n
            4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306e\u5c55\u671b\uff0c\u5317\u6d77\u9053\u6b6f\u5b66\u96d1\u8a8c\uff0c39(2), 151-155, 2019<\/li>\n<\/ol>\n

              2018<\/h4>\n
                \n
              1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\uff0cJournal of the Society of Japanese Women Scientists<\/em><\/strong>,\u00a0<\/em>18, 12-17, 2018<\/li>\n
              2. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u304c\u3093\u5275\u85ac\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2\uff0cPart \u2164\uff0c\u7b2c19\u7ae0\u201c\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u201d\uff0c\u5316\u5b66\u540c\u4eba\u7de8\u96c6\u90e8\uff0c2018\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n
              3. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u7de8\u96c6\uff0c\u65b0\u81e8\u5e8a\u816b\u760d\u5b66\uff08\u6539\u8a02\u7b2c5\u7248\uff09\uff0d\u304c\u3093\u85ac\u7269\u7642\u6cd5\u5c02\u9580\u533b\u306e\u305f\u3081\u306b\uff0d, \u201c\u8840\u7ba1\u65b0\u751f\u201d, \u5357\u6c5f\u5802, 48-51, 2018\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n<\/ol>\n

                2017<\/h4>\n
                  \n
                1. \u6a0b\u7530\u4eac\u5b50<\/span>\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u68ee\u672c\u771f\u5f18\uff1a\u843d\u8c37\u5b5d\u5e83\u76e3\u4fee\uff0c\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8\u3092\u3082\u305f\u3089\u3059\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u6a5f\u80fd\u7814\u7a76\u6700\u524d\u7dda\uff0c\u201c\u304c\u3093\u3068\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u201d\uff0c\u30a8\u30cc\u30fb\u30c6\u30a3\u30fc\u30fb\u30a8\u30b9\uff0c127-136, 2017\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n
                2. \u6a0b\u7530\u4eac\u5b50<\/u>, \u9593\u77f3\u5948\u6e56\uff1a\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u7cfb\u306e\u7570\u5e38,\u300c\u751f\u4f53\u306e\u79d1\u5b66 \u7279\u96c6 \u8840\u7ba1\u5236\u5fa1\u7cfb\u3068\u75be\u60a3\u300d\u533b\u5b66\u66f8\u9662, 68(4), 321\u2212323, 2017<\/li>\n<\/ol>\n

                  2016<\/h4>\n
                    \n
                  1. Hida K<\/span>, Maishi N, Annan DA and Hida Y\uff1aEdit by Takanori Kawaguchi, Cancer Metastasis and Cancer Stem Cell\/Niche, \u201cTumor Endthelial Cells and Cancer Progression\u201d, Bentham Books, 61-73, 2016\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n
                  2. \u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u30fb\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u5fb4\u3068\u305d\u306e\u5206\u5b50\u6a5f\u69cb\uff0c\u533b\u5b66\u306e\u3042\u3086\u307f\u201c\u304c\u3093\u5fae\u5c11\u74b0\u5883\u306e\u75c5\u614b\u7406\u89e3\u3068\u5236\u5fa1\u201d\uff0c258(1)\uff0c11-14\uff0c2016<\/li>\n
                  3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u30de\u30a4\u30af\u30edRNA\u3068\u8840\u7ba1\u75be\u60a3\uff0c\u300c\u8840\u7ba1\u533b\u5b66\uff1a\u4eca\u304c\u65ec\uff01\u30de\u30a4\u30af\u30edRNA\u30fb\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u6700\u524d\u7dda\u300d\uff0c17(1)\uff0c71-76\uff0c2016<\/li>\n
                  4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff0c\u5927\u8cc0\u5247\u5b5d\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u79cb\u5c71\u5ee3\u8f14\uff0c\u6a0b\u7530\u6cf0\u6d69\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u591a\u69d8\u6027\uff0c\u5225\u518aBIO Clinica \u6162\u6027\u708e\u75c7\u3068\u75be\u60a3\uff5e\u6162\u6027\u708e\u75c7\u3068\u304c\u3093\uff0c5(1)\uff0c\u5317\u9686\u9928\uff0c158-164\uff0c2016<\/li>\n
                  5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff0c\u9593\u77f3\u5948\u6e56\uff1a\u816b\u760d\u8840\u7ba1\u306e\u5206\u5b50\u751f\u7269\u5b66\u7684\u7279\u5fb4\uff0c\u300c\u7d30\u80de\u5de5\u5b66\uff5e\u7279\u96c6\u3000\u6297\u816b\u760d\u8840\u7ba1\u65b0\u751f\u7642\u6cd5\u306e\u65b0\u5c55\u958b\u300d35(1)\uff0c19-22\uff0c2016<\/li>\n<\/ol>\n

                    2015<\/h4>\n
                      \n
                    1. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u7de8\u96c6\uff0c\u65b0\u81e8\u5e8a\u816b\u760d\u5b66\uff0d\u304c\u3093\u85ac\u7269\u7642\u6cd5\u5c02\u9580\u533b\u306e\u305f\u3081\u306b\uff0d\uff0c\u201c\u8840\u7ba1\u65b0\u751f\u201d\uff0c\u5357\u6c5f\u5802\uff0c44-47, 2015\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n
                    2. \u6a0b\u7530\u4eac\u5b50<\/u>, \u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u6cf0\u6d69:\u816b\u760d\u8840\u7ba1\u306e\u7279\u6027\u3092\u6a19\u7684\u3068\u3057\u305f\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u5c55\u671b, \u00a0\u00a0\u9ad8\u5009\u4f38\u5e78\uff0c\u4f50\u8c37\u79c0\u884c\uff0c\u5927\u5cf6\u6b63\u4f38\uff0c\u77e2\u91ce\u8056\u4e8c\u7de8\u3000\u5b9f\u9a13\u533b\u5b66\u5897\u520a\u300c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u3068\u6a19\u7684\u6cbb\u7642\u300d33(5)\uff0c134-138\uff0c2015<\/li>\n
                    3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u8107\u7530\u3000\u7a14\uff0c\u524d\u7530\u5065\u5eb7\uff0c\u4e2d\u6751\u6d69\u5f70\uff0c\u7db2\u585a\u61b2\u751f\u7de8\uff0c\u53e3\u8154\u7d44\u7e54\u30fb\u767a\u751f\u5b66\u3000\u7b2c2\u7248\uff0c\u201c\u764c\u3068\u8840\u7ba1\u65b0\u751f\u201d\uff0c\u533b\u6b6f\u85ac\u51fa\u7248\uff0c221-223\uff0c2015\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n<\/ol>\n

                      2014<\/h4>\n
                        \n
                      1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306e\u4eca\u5f8c\u306e\u5c55\u671b\uff0c\u300cSurgery Frontier\uff5e\u7279\u96c6\uff1a\u764c\u3068\u5fae\u5c0f\u74b0\u5883\u300d\uff0c21(2)\uff0c53-57\uff0c2014<\/li>\n
                      2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u7279\u7570\u6027\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6226\u7565\u3078\u306e\u5c55\u671b,\u300c\u75c5\u7406\u3068\u81e8\u5e8a\uff5e\u7279\u96c6\uff1a\u304c\u3093\u3068\u9593\u8cea\u300d, 32(1), 45-50, 2014<\/li>\n<\/ol>\n

                        2013<\/h4>\n
                          \n
                        1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u7279\u7570\u6027\u3068\u65b0\u898f\u6cbb\u7642\u3078\u306e\u5fdc\u7528,\u300c\u304c\u3093\u5206\u5b50\u6a19\u7684\u6cbb\u7642\u3000\u5225\u518a\u300d,11(2), 55-58, 2013<\/li>\n
                        2. \u79cb\u5c71\u5ee3\u8f14,\u3000\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\u3068\u6cbb\u7642\u611f\u53d7\u6027,\u300c\u6700\u65b0\u533b\u5b66\u300d,68(12), 40-45, 2013<\/li>\n
                        3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u4f50\u85e4\u9756\u53f2\uff0c\u9ad9\u5009\u4f38\u5e78\u7de8\uff0c\u8840\u7ba1\u65b0\u751f\u7814\u7a76\u306e\u6700\u5148\u7aef\uff0c\u201c\u8840\u7ba1\u65b0\u751f\u3068\u75c5\u614b\uff0d\u816b\u760d\u8840\u7ba1\u65b0\u751f\u201d\uff0c\u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb\u793e\uff0c254-262\uff0c2013\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n<\/ol>\n

                          2012<\/h4>\n
                            \n
                          1. \u6a0b\u7530\u4eac\u5b50<\/u>, \u5927\u8cc0\u5247\u5b5d, \u79cb\u5c71\u5ee3\u8f14, \u9593\u77f3\u5948\u6e56\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u3068\u764c\u306e\u60aa\u6027\u5316\u3068\u306e\u95a2\u9023, \u65e5\u672c\u53e3\u8154\u816b\u760d\u5b66\u4f1a\u8a8c, 24(3), 88-94, 2012<\/li>\n
                          2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u3068\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de, \u201cDrug Delivery System\u201d, \u7279\u96c6\uff62\u57fa\u790e\u304b\u3089\u62d3\u304fDDS\u5275\u85ac\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2\uff63\u65e5\u672cDDS\u5b66\u4f1a, 27(1), 34-39, 2012<\/li>\n
                          3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027,\u300c\u751f\u5316\u5b66\u300d, \u793e\u56e3\u6cd5\u4eba\u65e5\u672c\u751f\u5316\u5b66\u4f1a, 84(1), 43-46, 2012<\/li>\n<\/ol>\n

                            2011<\/h4>\n
                              \n
                            1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u4f50\u85e4\u9756\u53f2, \u68ee\u7530\u80b2\u7537, \u9ad8\u5009\u4f38\u5e78, \u5c0f\u5ba4\u4e00\u6210\u76e3\u4fee, \u65e5\u672c\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u7de8\u300c\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4e8b\u5178\u300d, \u201cVascular mimicry\u201d, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u201d, \u671d\u5009\u66f8\u5e97, 206-209, 2011<\/li>\n<\/ol>\n

                              2009<\/h4>\n
                                \n
                              1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u6cbb\u7642\u62b5\u6297\u6027, \u4e38\u5c71\u5f81\u90ce, \u5b89\u85e4\u4e08\u6cbb, \u4f50\u85e4\u9756\u53f2, \u5009\u6797\u6b63\u5f66, \u6c5f\u982d\u5065\u8f14, \u5c71\u5cb8\u660c\u4e00\u7de8\u3000\u8840\u7ba1\u533b\u5b66 \u7279\u96c6\u300c\u304c\u3093\u3068\u8840\u7ba1\uff0d\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u304b\u3089\u6cbb\u7642\u307e\u3067\uff0d\u300d, \u30e1\u30c7\u30a3\u30ab\u30eb\u30ec\u30d3\u30e5\u30fc\u793e, 10(4), 23-28, 2009<\/li>\n
                              2. \u6a0b\u7530\u4eac\u5b50<\/u>, \u79cb\u91ce\u6587\u81e3, \u6a0b\u7530\u6cf0\u6d69\uff1a\u304c\u3093\u7d44\u7e54\u4e2d\u306e\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\uff0d\u907a\u4f1d\u5b50\u767a\u73fe\u304b\u3089\u67d3\u8272\u4f53\u7570\u5e38\u307e\u3067, \u843d\u5408\u6df3\u5fd7\u30fb\u9ad8\u5009\u4f38\u5e78\u7de8\u3000\u5b9f\u9a13\u533b\u5b66\u5897\u520a\u53f7\u300c\u764c\u306e\u5fae\u5c0f\u74b0\u5883\u3068\u9069\u5fdc\u5fdc\u7b54\u306e\u6700\u524d\u7dda\u300d, \u7f8a\u571f\u793e, 27(2), 149-155, 2009<\/li>\n<\/ol>\n

                                2008\u5e74\u4ee5\u524d<\/h4>\n
                                  \n
                                1. \u6a0b\u7530\u4eac\u5b50,<\/u> \u6a0b\u7530\u6cf0\u6d69\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3001\u8840\u7ba1\u65b0\u751fup-to-date\u3000\u6e0b\u8c37\u6b63\u53f2\u30fb\u4f50\u85e4\u9756\u53f2\u7de8\u300c\u7d30\u80de\u300d, \u30cb\u30e5\u30fc\u30b5\u30a4\u30a8\u30f3\u30b9\u793e, 40(12), 16-19, 2008<\/li>\n
                                2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u78c1\u6c17\u30d3\u30fc\u30ba\u3092\u7528\u3044\u305f\u304c\u3093\u7d44\u7e54\u304b\u3089\u306e\u7d30\u80de\u5206\u96e2\u6cd5\u3000\u304c\u3093\u8ee2\u79fb\u7814\u7a76\u306e\u5b9f\u9a13\u624b\u6cd5\u3000\u7b2c1\u7248, \u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u7de8\u3000\u6e05\u6728\u5143\u6cbb\u30fb\u611b\u7532\u5b5d\u3000\u7de8\u91d1\u82b3\u5802, 211-214, 2008<\/li>\n
                                3. \u6a0b\u7530\u4eac\u5b50, <\/u>\u6a0b\u7530\u6cf0\u6d69\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\uff0d\u7406\u60f3\u7684\u306a\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u306e\u958b\u767a\u3092\u76ee\u6307\u3057\u3066, \u7dcf\u8aac\u3000\u5b9f\u9a13\u533b\u5b66\u5897\u520a\u53f7\u300c\u6025\u901f\u9032\u5c55\u3059\u308b\u8840\u7ba1\u7814\u7a76\u300d, \u7f8a\u571f\u793e, 24(18), 152-157, 2006<\/li>\n
                                4. Shindoh M, Fujinaga K, Hida K<\/u>, Funaoka K\uff1aPCR application for paraffin-embedded tissues, Tanpakushitsu kakusan koso. Protein, nucleic acid, 41, 463-466, 1996<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                                  2025 \u6a0b\u7530\u4eac\u5b50\uff1a\u8840\u7ba1\u306e\u708e\u75c7\u6027\u5909\u5316\u3068\u75c5\u614b\u9032\u884c, \u75c5\u7406\u3068\u81e8\u5e8a, \u6587\u5149\u5802 43(7), 733-735, 2025 2024 \u6a0b\u7530\u4eac\u5b50: \u6b6f\u5b66\u751f\u306e\u305f\u3081\u306e\u57fa\u790e\u75c5\u7406\u5b66, Chapter8 \u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u304a\u3088\u3073\u767a\u751f\u306e\u7570\u5e38, \u201c\u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u306e\u57fa\u672c\u201d, \u533b\u6b6f\u85ac\u51fa\u7248, 170-175, 2024\uff08\u5206\u62c5\u57f7\u7b46\uff09 2023 \u6a0b\u7530\u4eac\u5b50: \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u7de8\u96c6\uff0c\u65b0\u81e8\u5e8a\u816b\u760d\u5b66\uff08\u6539\u8a02\u7b2c7\u7248\uff09\uff0d\u304c\u3093\u306e\u767a\u751f\u3068\u9032\u5c55\u6a5f\u69cb\uff0d, \u201c\u8840…\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-18","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/18","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/comments?post=18"}],"version-history":[{"count":59,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/18\/revisions"}],"predecessor-version":[{"id":1432,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/18\/revisions\/1432"}],"wp:attachment":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/media?parent=18"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}